Passage Bio Analyst Price Targets - Benzinga

SPY757.05 QQQ686.59+0.19%BTC/USD78,332.84+1.28%DIA521.20+0.80%GLD370.58+3.15%TLT81.49+0.47%

Premium Services

Premium Services

Passage Bio Inc

PASGNASDAQ

Trade with Public

Trade with Public

$3.40

0.082.41%

Last update: Nov 3, 9:21 AM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Passage Bio Analyst Price Targets - Benzinga

Passage Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Passage Bio (PASG).

Price Target Range — 11 Quarters

Analyst Consensus — 8 Analysts

5Buy

3Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$14Upside to Avg. PT+321.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 21, 2026	TD Cowen	Brendan Smith	Downgrade	Buy→Hold	—
Apr 21, 2026	Chardan Capital	Janani Sundararajan	Downgrade	Buy→Neutral	$21→$7
Apr 21, 2026	Oppenheimer	Jay Olson	PT Cut	Outperform	$30→$15
Apr 21, 2026	Wedbush	Yun Zhong	Downgrade	Outperform→Neutral	$32→$8
Mar 31, 2026	Oppenheimer	Jay Olson	Initiate	Outperform	$30
Mar 4, 2026	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$67→$23
Nov 12, 2025	Chardan Capital	Geulah Livshits	PT Raise	Buy	$6→$21
Aug 14, 2025	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$260→$67
Aug 14, 2025	Guggenheim	Debjit Chattopadhyay	PT Cut	Buy	$40→$10
Aug 13, 2025	Wedbush	Yun Zhong	PT Raise	Outperform	$3→$40
Jun 24, 2025	Chardan Capital	Geulah Livshits	Maintained	Buy	$120
Mar 4, 2025	Chardan Capital	Geulah Livshits	PT Cut	Buy	$140→$120
Nov 29, 2024	Wedbush	Yun Zhong	Assumes	Outperform	$80
Nov 14, 2024	Chardan Capital	Geulah Livshits	Maintained	Buy	$140
Nov 14, 2024	Canaccord Genuity	Whitney Ijem	Maintained	Buy	$260
Sep 17, 2024	Canaccord Genuity	Whitney Ijem	Maintained	Buy	$260
Sep 3, 2024	Rodman & Renshaw	—	Initiate	Buy	$140
May 15, 2024	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$280→$260
Mar 5, 2024	Canaccord Genuity	Whitney Ijem	Maintained	Buy	$280
Dec 21, 2023	Canaccord Genuity	Whitney Ijem	PT Raise	Buy	$160→$280

Analyst Ratings News

PRO
TD Cowen Downgrades Passage Bio to Hold

TD Cowen analyst Brendan Smith downgrades Passage Bio (NASDAQ:PASG) from Buy to Hold.

Benzinga Newsdesk

PRO
Chardan Capital Downgrades Passage Bio to Neutral, Lowers Price Target to $7

Chardan Capital analyst Janani Sundararajan downgrades Passage Bio (NASDAQ:PASG) from Buy to Neutral and lowers the price target from $21 to $7.

Benzinga Newsdesk

This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday

Wall Street analysts changed outlook for top names, including downgrading Mohawk Industries and Passage Bio. See analyst ratings for these stocks.

Avi Kapoor

PRO
Oppenheimer Maintains Outperform on Passage Bio, Lowers Price Target to $15

Oppenheimer analyst Jay Olson maintains Passage Bio (NASDAQ:PASG) with a Outperform and lowers the price target from $30 to $15.

Benzinga Newsdesk

PRO
Wedbush Downgrades Passage Bio to Neutral, Lowers Price Target to $8

Wedbush analyst Yun Zhong downgrades Passage Bio (NASDAQ:PASG) from Outperform to Neutral and lowers the price target from $32 to $8.

Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Passage Bio with Outperform Rating, Announces Price Target of $30

Oppenheimer analyst Jay Olson initiates coverage on Passage Bio (NASDAQ:PASG) with a Outperform rating and announces Price Target of $30.

Benzinga Newsdesk